Davita Inc (NYSE:DVA) Shares Acquired by California Public Employees Retirement System

California Public Employees Retirement System increased its position in shares of Davita Inc (NYSE:DVA) by 6.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 361,737 shares of the company’s stock after acquiring an additional 21,438 shares during the period. California Public Employees Retirement System owned about 0.23% of Davita worth $20,644,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. North Star Investment Management Corp. acquired a new position in Davita during the 3rd quarter worth about $46,000. Rehmann Capital Advisory Group lifted its stake in Davita by 51.3% during the 2nd quarter. Rehmann Capital Advisory Group now owns 841 shares of the company’s stock worth $47,000 after acquiring an additional 285 shares in the last quarter. Employers Holdings Inc. acquired a new position in Davita during the 2nd quarter worth about $56,000. NuWave Investment Management LLC lifted its stake in Davita by 1,166.3% during the 3rd quarter. NuWave Investment Management LLC now owns 1,013 shares of the company’s stock worth $57,000 after acquiring an additional 933 shares in the last quarter. Finally, Neo Ivy Capital Management acquired a new position in Davita during the 2nd quarter worth about $61,000. 91.00% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NYSE DVA opened at $69.85 on Friday. The stock’s 50-day moving average is $58.51 and its two-hundred day moving average is $55.70. The company has a debt-to-equity ratio of 1.90, a current ratio of 1.12 and a quick ratio of 1.10. Davita Inc has a 1-year low of $43.40 and a 1-year high of $70.51. The company has a market cap of $10.01 billion, a price-to-earnings ratio of 19.57, a price-to-earnings-growth ratio of 0.62 and a beta of 1.59.

Davita (NYSE:DVA) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.53 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.24 by $0.29. Davita had a return on equity of 18.03% and a net margin of 3.68%. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $2.85 billion. During the same quarter in the prior year, the business earned $0.56 EPS. Davita’s revenue was up 2.0% on a year-over-year basis. Equities research analysts anticipate that Davita Inc will post 5.19 earnings per share for the current fiscal year.

DVA has been the topic of several research reports. TheStreet raised Davita from a “c+” rating to a “b-” rating in a research note on Wednesday, July 24th. William Blair lowered Davita from an “outperform” rating to a “market perform” rating in a research note on Wednesday, September 11th. Robert W. Baird lowered Davita from an “outperform” rating to a “neutral” rating and decreased their target price for the stock from $70.00 to $65.00 in a research note on Friday, July 26th. UBS Group decreased their target price on Davita from $61.00 to $60.00 and set a “neutral” rating on the stock in a research note on Thursday, August 22nd. Finally, SunTrust Banks increased their target price on Davita to $72.00 and gave the stock a “hold” rating in a research note on Wednesday. Nine research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $64.81.

Davita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Recommended Story: How a Strangle Strategy is different from a Straddle Strategy

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.